AW
UTHR icon

Alpha Windward’s United Therapeutics UTHR Stock Holding History

Alpha Windward’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-84
Closed -$8K – 343
2020
Q3 		$8K Sell
84
-57
-40% -$6.25K 0.01% 371
2020
Q2 		$17K Sell
141
-90
-39% -$10.1K 0.01% 333
2020
Q1 		$22K Sell
231
-5,280
-96% -$502K 0.02% 312
2019
Q4 		$485K Buy
5,511
+5,377
+4,013% +$473K 0.31% 108
2019
Q3 		$11K Hold
134
– – 0.01% 365
2019
Q2 		$10K Buy
+134
New +$12.5K 0.01% 370
2018
Q2 		– Sell
-270
Closed -$30K – 459
2018
Q1 		$30K Hold
270
– – 0.02% 337
2017
Q4 		$40K Buy
270
+203
+303% +$25.8K 0.02% 316
2017
Q3 		$8K Hold
67
– – ﹤0.01% 396
2017
Q2 		$9K Sell
67
-205
-75% -$25.6K 0.01% 392
2017
Q1 		$37K Hold
272
– – 0.02% 330
2016
Q4 		$39K Buy
+272
New +$34.7K 0.03% 310

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Alpha Windward's UTHR Position: Q4 2020 in Review

Alpha Windward sold out of United Therapeutics (UTHR) in Q4 2020, closing a stake of 84 shares — an estimated $8K sold.

Alpha Windward first reported a position in UTHR in Q4 2016 and held it in 12 quarters. The position peaked at $485K in Q4 2019. 356 funds tracked by Wall St. Rank hold UTHR as of Q4 2020.

  • Alpha Windward reported no remaining United Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Alpha Windward sold 84 United Therapeutics shares in Q4 2020, an estimated $8K.
  • Alpha Windward first reported a position in United Therapeutics in Q4 2016 and held it in 12 quarters.
  • Alpha Windward's United Therapeutics position peaked at $485K in Q4 2019.
  • 356 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2020.

Based on Alpha Windward's 13F filing for Q4 2020.